Clinuvel Pharmaceuticals Limited
CLVLF
$7.96
-$0.1583-1.95%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 122.67M | 137.43M | 122.68M | 119.90M | 118.92M |
| Total Receivables | 10.08M | 11.29M | 17.51M | 17.11M | 8.91M |
| Inventory | 5.82M | 6.52M | 7.09M | 6.93M | 8.56M |
| Prepaid Expenses | 2.26M | 2.53M | -- | -- | 964.70K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 887.70K | 867.60K | -- |
| Total Current Assets | 140.83M | 157.78M | 148.16M | 144.81M | 137.35M |
|
|
|||||
| Total Current Assets | 140.83M | 157.78M | 148.16M | 144.81M | 137.35M |
| Net Property, Plant & Equipment | 4.40M | 4.93M | 5.15M | 5.03M | 5.38M |
| Long-term Investments | -- | -- | -- | -- | 126.10K |
| Goodwill | -- | -- | -- | -- | 126.10K |
| Total Other Intangibles | 114.50K | 128.30K | 123.50K | 120.70K | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 749.80K | 840.00K | 680.80K | 665.40K | 1.44M |
| Total Assets | 146.18M | 163.77M | 154.21M | 150.72M | 144.30M |
|
|
|||||
| Total Accounts Payable | 3.50M | 3.92M | 1.56M | 1.53M | 4.42M |
| Total Accrued Expenses | 1.19M | 1.33M | 1.26M | 1.23M | 1.16M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 240.50K | 269.50K | 246.80K | 241.20K | 242.50K |
| Total Finance Division Other Current Liabilities | 3.18M | 3.57M | 13.75M | 13.44M | 14.21M |
| Total Other Current Liabilities | 3.18M | 3.57M | 13.75M | 13.44M | 14.21M |
| Total Current Liabilities | 8.11M | 9.09M | 16.82M | 16.44M | 20.03M |
|
|
|||||
| Total Current Liabilities | 8.11M | 9.09M | 16.82M | 16.44M | 20.03M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 202.20K | 226.50K | 340.20K | 332.50K | 486.10K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.39M | 3.79M | 1.59M | 1.56M | 2.00M |
| Total Liabilities | 11.70M | 13.11M | 18.76M | 18.33M | 22.52M |
|
|
|||||
| Common Stock & APIC | 104.31M | 116.86M | 112.63M | 110.08M | 115.58M |
| Retained Earnings | 25.70M | 28.80M | 19.99M | 19.54M | 3.59M |
| Treasury Stock & Other | 4.47M | 5.00M | 2.83M | 2.77M | 2.61M |
| Total Common Equity | 134.48M | 150.66M | 135.45M | 132.38M | 121.78M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 134.48M | 150.66M | 135.45M | 132.38M | 121.78M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 134.48M | 150.66M | 135.45M | 132.38M | 121.78M |
|
|
|||||